[
    {
        "speaker": "Tom Mansell",
        "timestamp": "00:00-00:13",
        "transcript": "Sensing and regulation is a big part of the plan here. But for now, we're in the very preliminary stages of that.",
        "speaking_duration": 13,
        "nods_others": 2,
        "smile_self": 0,
        "smile_other": 0,
        "distracted_others": 0,
        "hand_gesture": "None",
        "interuption": "No",
        "overlap": "No",
        "screenshare": "Yes",
        "screenshare_content": "A document is shared on the screen. The document appears to be a research plan or proposal. No changes are made to the document during this segment.",
        "start_time": "00:00",
        "end_time": "00:13",
        "annotations": {
            "develop idea": "The speaker is discussing and elaborating on aspects of the plan, specifically mentioning sensing and regulation as a big part of it.",
            "identify gap": "The speaker acknowledges that they are in the very preliminary stages of the plan, indicating a gap in progress."
        }
    },
    {
        "speaker": "Tanya Nguyen",
        "timestamp": "00:13-01:02",
        "transcript": "To follow up on what you're saying and also what Jay had mentioned earlier, and I have no idea how to do this, but it would be so cool to develop a way to kind of individually determine what someone's microbiome is at homeostasis, their ideal kind of microbiome environment, whether that be composition, metabolites, chemicals, and then use that as a baseline, and then being able to develop, you know, these different chemically engineered bacteria then produce specific metabolites to keep that person at that specific ideal level or attain an ideal level for them to then minimize their clinical symptoms or functioning. I think that would be a really cool idea, no idea how to get there, but happy to talk about it further and develop that.",
        "speaking_duration": 49,
        "nods_others": 3,
        "smile_self": 20,
        "smile_other": 10,
        "distracted_others": 0,
        "hand_gesture": "Open Palms",
        "interuption": "Yes",
        "overlap": "No",
        "screenshare": "Yes",
        "screenshare_content": "The same document remains shared on the screen. No changes are made to the document during this segment.",
        "start_time": "00:13",
        "end_time": "01:02",
        "annotations": {
            "propose new idea": "The utterance introduces a novel concept of using chemically engineered bacteria to produce specific metabolites based on an individual's ideal microbiome environment.",
            "identify gap": "The speaker mentions 'no idea how to do this,' explicitly recognizing a lack of knowledge on how to achieve the proposed idea.",
            "encourage participation": "The speaker invites further discussion by saying 'happy to talk about it further and develop that.'"
        }
    },
    {
        "speaker": "Tom Mansell",
        "timestamp": "01:02-01:13",
        "transcript": "I think you could do it with one molecule. I don't know about all of those. But you know, if it's short chain fatty acids, I think that that's a great idea.",
        "speaking_duration": 11,
        "nods_others": 0,
        "smile_self": 30,
        "smile_other": 60,
        "distracted_others": 0,
        "hand_gesture": "None",
        "interuption": "No",
        "overlap": "No",
        "screenshare": "Yes",
        "screenshare_content": "The same document remains shared on the screen. No changes are made to the document during this segment.",
        "start_time": "01:02",
        "end_time": "01:13",
        "annotations": {
            "develop idea": "The speaker is expanding on Tanya Nguyen's idea by suggesting a possible approach and showing interest in a specific aspect of it.",
            "supportive response": "The speaker is expressing a positive evaluation of a part of Tanya Nguyen's idea.",
            "offer feedback": "The speaker provides a suggestion or a possible approach for Tanya Nguyen's idea."
        }
    },
    {
        "speaker": "Tom Mansell",
        "timestamp": "01:13-01:26",
        "transcript": "Right now, I think, in general, the approaches, well, let's just make more, make more given prebiotics, given probiotics that we think are going to make butyrate. But you know, there might, there's probably a level that's too high, right?",
        "speaking_duration": 13,
        "nods_others": 1,
        "smile_self": 0,
        "smile_other": 0,
        "distracted_others": 0,
        "hand_gesture": "None",
        "interuption": "No",
        "overlap": "No",
        "screenshare": "Yes",
        "screenshare_content": "The same document remains shared on the screen. No changes are made to the document during this segment.",
        "start_time": "01:13",
        "end_time": "01:26",
        "annotations": {
            "develop idea": "The speaker is expanding on previous ideas, specifically discussing the current approaches to making butyrate using prebiotics and probiotics.",
            "offer feedback": "The speaker is providing a perspective on the current approach and its potential limitations, suggesting there might be a level of butyrate that's too high."
        }
    },
    {
        "speaker": "Tom Mansell",
        "timestamp": "01:26-01:38",
        "transcript": "Do they take 12 different probiotic supplements every day to maintain that? You know, that's kind of the, yeah, so.",
        "speaking_duration": 12,
        "nods_others": 0,
        "smile_self": 40,
        "smile_other": 0,
        "distracted_others": 0,
        "hand_gesture": "None",
        "interuption": "No",
        "overlap": "No",
        "screenshare": "Yes",
        "screenshare_content": "The same document remains shared on the screen. No changes are made to the document during this segment.",
        "start_time": "01:26",
        "end_time": "01:38",
        "annotations": {
            "ask question": "The utterance explicitly asks a question about taking probiotic supplements, seeking information on current practices.",
            "critical response": "The question implies a potential issue or concern with the current practice of taking many probiotic supplements."
        }
    },
    {
        "speaker": "Tom Mansell",
        "timestamp": "01:40-01:56",
        "transcript": "Yeah, no, that's a good idea. I mean, there is this whole, you know, what's a healthy microbiome, what's a healthy metabolome. That's, I think, going to vary by the host, and these host factors really influence these things, right? So, in addition to diet, of course, right?",
        "speaking_duration": 18,
        "nods_others": 1,
        "smile_self": 0,
        "smile_other": 0,
        "distracted_others": 0,
        "hand_gesture": "None",
        "interuption": "No",
        "overlap": "No",
        "screenshare": "Yes",
        "screenshare_content": "The same document remains shared on the screen. No changes are made to the document during this segment.",
        "start_time": "01:40",
        "end_time": "01:56",
        "annotations": {
            "supportive response": "The speaker expresses agreement and validation for Tanya Nguyen's idea.",
            "develop idea": "The speaker expands on the idea by discussing the complexity of a healthy microbiome and metabolome."
        }
    },
    {
        "speaker": "Tom Mansell",
        "timestamp": "01:56-02:07",
        "transcript": "You can blame it on behavior a little bit, but also there's probably genetic factors too, right, that influence your microbiome. I'm just gabbling, yeah.",
        "speaking_duration": 11,
        "nods_others": 0,
        "smile_self": 20,
        "smile_other": 0,
        "distracted_others": 0,
        "hand_gesture": "None",
        "interuption": "No",
        "overlap": "No",
        "screenshare": "Yes",
        "screenshare_content": "The same document remains shared on the screen. No changes are made to the document during this segment.",
        "start_time": "01:56",
        "end_time": "02:07",
        "annotations": {
            "develop idea": "Tom is expanding on the idea that factors influencing the microbiome are multifaceted, including both behavior and genetic factors.",
            "express humor": "Tom makes a light-hearted comment by saying 'I'm just gabbling, yeah,' which can be considered as expressing humor."
        }
    },
    {
        "speaker": "Jae Sung",
        "timestamp": "02:15-02:23",
        "transcript": "I guess we have many more questions than answers. That's because that's how science works. Very interesting.",
        "speaking_duration": 8,
        "nods_others": 0,
        "smile_self": 80,
        "smile_other": 0,
        "distracted_others": 0,
        "hand_gesture": "None",
        "interuption": "No",
        "overlap": "No",
        "screenshare": "Yes",
        "screenshare_content": "The same document remains shared on the screen. No changes are made to the document during this segment.",
        "start_time": "02:15",
        "end_time": "02:23",
        "annotations": {
            "identify gap": "Jae Sung explicitly recognizes the current state of having more questions than answers, indicating a gap in knowledge.",
            "supportive response": "The utterance expresses a positive tone towards the discussion, acknowledging its interest and potential, without adding new content."
        }
    },
    {
        "speaker": "Tom Mansell",
        "timestamp": "02:27-02:46",
        "transcript": "I just have to say, as a chemical engineer, the thing that I have gotten most out of this discussion is this motility concept, right? And so we talked, you know, Emily framed the discussion as, this is a bioreactor, right? This is, we have a whole core curriculum on this on reactor design.",
        "speaking_duration": 19,
        "nods_others": 0,
        "smile_self": 20,
        "smile_other": 0,
        "distracted_others": 0,
        "hand_gesture": "None",
        "interuption": "No",
        "overlap": "No",
        "screenshare": "Yes",
        "screenshare_content": "The same document remains shared on the screen. No changes are made to the document during this segment.",
        "start_time": "02:27",
        "end_time": "02:46",
        "annotations": {
            "signal expertise": "Tom Mansell explicitly states his own expertise as a chemical engineer.",
            "acknowledge contribution": "Tom Mansell verbally recognizes Emily's input in framing the discussion.",
            "develop idea": "Tom Mansell expands on the discussion by relating the motility concept to reactor design, using his engineering background."
        }
    },
    {
        "speaker": "Tom Mansell",
        "timestamp": "02:46-03:17",
        "transcript": "A key parameter of reactor design is residence time, which is the flow rate divided by the volume, right? So, that motility, being the flow rate, is going to influence the conversion or whatever fermentation products come out of your reactor, right? And so, I love this idea of influencing motility as a way to manipulate the microbiome, and in doing so, manipulate the metabolome.",
        "speaking_duration": 31,
        "nods_others": 1,
        "smile_self": 20,
        "smile_other": 0,
        "distracted_others": 0,
        "hand_gesture": "None",
        "interuption": "No",
        "overlap": "No",
        "screenshare": "Yes",
        "screenshare_content": "The same document remains shared on the screen. No changes are made to the document during this segment.",
        "start_time": "02:46",
        "end_time": "03:17",
        "annotations": {
            "develop idea": "The speaker is expanding on an existing idea by providing a detailed explanation using specific terms from reactor design to support the concept of influencing motility as a way to manipulate the microbiome and metabolome.",
            "offer feedback": "The speaker provides a detailed explanation that can be seen as offering feedback on how to approach manipulating the microbiome, by explaining how motility can influence the conversion or fermentation products in a reactor."
        }
    },
    {
        "speaker": "Faranak Fattahi",
        "timestamp": "03:18-03:22",
        "transcript": "It's circular, and then it affects motility again.",
        "speaking_duration": 4,
        "nods_others": 0,
        "smile_self": 60,
        "smile_other": 20,
        "distracted_others": 0,
        "hand_gesture": "Pointing",
        "interuption": "Yes",
        "overlap": "No",
        "screenshare": "Yes",
        "screenshare_content": "The same document remains shared on the screen. No changes are made to the document during this segment.",
        "start_time": "03:18",
        "end_time": "03:22",
        "annotations": {
            "None": "No relevant code explicitly applies to this utterance as it does not clearly fit into any of the provided categories."
        }
    },
    {
        "speaker": "Tom Mansell",
        "timestamp": "03:22-03:23",
        "transcript": "Right.",
        "speaking_duration": 1,
        "nods_others": 0,
        "smile_self": 0,
        "smile_other": 80,
        "distracted_others": 0,
        "hand_gesture": "None",
        "interuption": "No",
        "overlap": "No",
        "screenshare": "Yes",
        "screenshare_content": "The same document remains shared on the screen. No changes are made to the document during this segment.",
        "start_time": "03:22",
        "end_time": "03:23",
        "annotations": {
            "None": "No relevant code applies to this utterance as it is a minimal response."
        }
    },
    {
        "speaker": "Tom Mansell",
        "timestamp": "03:23-03:41",
        "transcript": "Yes, of course. And you know, like many processes, it probably is a small disruption that becomes non-linear, and then, you know, that's when you end up in a disease state. I don't know, I'm not that kind of doctor, but",
        "speaking_duration": 18,
        "nods_others": 0,
        "smile_self": 20,
        "smile_other": 0,
        "distracted_others": 0,
        "hand_gesture": "None",
        "interuption": "No",
        "overlap": "No",
        "screenshare": "Yes",
        "screenshare_content": "The same document remains shared on the screen. No changes are made to the document during this segment.",
        "start_time": "03:23",
        "end_time": "03:41",
        "annotations": {
            "Supportive response": "The speaker expresses agreement and validation with previous discussion.",
            "Develop idea": "The speaker expands on the idea that small disruptions can lead to disease states.",
            "Identify gap": "The speaker indicates a limitation in their expertise by saying 'I'm not that kind of doctor'."
        }
    },
    {
        "speaker": "Tom Mansell",
        "timestamp": "03:41-03:46",
        "transcript": "So, Faranak, I think we should talk about your ENS essay a little more.",
        "speaking_duration": 5,
        "nods_others": 0,
        "smile_self": 20,
        "smile_other": 60,
        "distracted_others": 0,
        "hand_gesture": "None",
        "interuption": "No",
        "overlap": "No",
        "screenshare": "Yes",
        "screenshare_content": "The same document remains shared on the screen. No changes are made to the document during this segment.",
        "start_time": "03:41",
        "end_time": "03:46",
        "annotations": {
            "encourage participation": "The speaker invites Faranak to discuss their ENS essay, encouraging Faranak's participation.",
            "process management": "The speaker manages the discussion flow by suggesting a new topic to explore."
        }
    },
    {
        "speaker": "Faranak Fattahi",
        "timestamp": "03:46-04:15",
        "transcript": "Absolutely. Yeah, I'd love to. So we have actually done a lot of high throughput assays just looking at, you know, a library of neuroactive compounds. So these are around maybe 500 or 600 just small molecules that affect different neurotransmitter receptors. And turns out a lot of neurons in the GI tract respond to a variety of different neurotransmitter agonists and antagonists. And many of them could be influenced by microbial products.",
        "speaking_duration": 29,
        "nods_others": 2,
        "smile_self": 40,
        "smile_other": 0,
        "distracted_others": 0,
        "hand_gesture": "None",
        "interuption": "No",
        "overlap": "No",
        "screenshare": "Yes",
        "screenshare_content": "The same document remains shared on the screen. No changes are made to the document during this segment.",
        "start_time": "03:46",
        "end_time": "04:15",
        "annotations": {
            "signal expertise": "The speaker is explicitly stating their experience and qualifications in the field by sharing specific details about their research."
        }
    },
    {
        "speaker": "Emily Balskus",
        "timestamp": "00:03-00:26",
        "transcript": "Okay, so we we probably have five minutes or so left, maybe um uh yeah, so thinking about and it looks like Jay Jay might have stepped away from his computer. Thinking about you sort of condensing and highlighting the key takeaways, um yeah, maybe Sarah.",
        "speaking duration": 23,
        "nods_others": 1,
        "smile_self": 65,
        "smile_other": 0,
        "distracted_others": 0,
        "hand_gesture": "Open Palms",
        "interuption": "No",
        "overlap": "No",
        "screenshare": "Yes",
        "screenshare_content": "A document titled \"Group 1.3 Key points and next steps\" is being shared. The document appears to be a list of bullet points, possibly summarizing key findings or action items. No changes are made to the content during this segment.",
        "start_time": "10:03",
        "end_time": "10:26",
        "annotations": {
            "process management": "The speaker is managing the meeting flow by mentioning the remaining time.",
            "encourage participation": "The speaker is inviting Sarah to contribute by condensing and highlighting key takeaways."
        }
    },
    {
        "speaker": "Faranak Fattahi",
        "timestamp": "00:26-00:57",
        "transcript": "I guess for me the the main takeaways are we have um so the field has identified many interesting correlations between um certain fermentation products and neurological disorders. Um and so we know that those actually are relevant to actual clinical data and in my mouse models. And so we are expanding, we are hoping to expand our knowledge of what other products might be important in like overall neurological.",
        "speaking duration": 31,
        "nods_others": 0,
        "smile_self": 0,
        "smile_other": 100,
        "distracted_others": 0,
        "hand_gesture": "None",
        "interuption": "No",
        "overlap": "No",
        "screenshare": "Yes",
        "screenshare_content": "A document titled \"Group 1.3 Key points and next steps\" is being shared. The document appears to be a list of bullet points, possibly summarizing key findings or action items. No changes are made to the content during this segment.",
        "start_time": "10:26",
        "end_time": "10:57",
        "annotations": {
            "Summarize conversation": "The speaker is summarizing key points from previous discussions, highlighting correlations between fermentation products and neurological disorders, and future directions.",
            "Develop idea": "The speaker is building upon existing ideas by explaining their current understanding and plans for expansion."
        }
    },
    {
        "speaker": "Emily Balskus",
        "timestamp": "00:57-00:58",
        "transcript": "Oh we really don't have yeah.",
        "speaking duration": 1,
        "nods_others": 0,
        "smile_self": 100,
        "smile_other": 0,
        "distracted_others": 0,
        "hand_gesture": "None",
        "interuption": "No",
        "overlap": "Yes",
        "screenshare": "Yes",
        "screenshare_content": "A document titled \"Group 1.3 Key points and next steps\" is being shared. The document appears to be a list of bullet points, possibly summarizing key findings or action items. No changes are made to the content during this segment.",
        "start_time": "10:57",
        "end_time": "10:58",
        "annotations": {
            "acknowledge contribution": "Emily Balskus is acknowledging Faranak Fattahi's contribution by responding to her summary.",
            "identify gap": "Emily's response could also imply a recognition of a lack of something, possibly data or understanding."
        }
    },
    {
        "speaker": "Faranak Fattahi",
        "timestamp": "01:00-01:44",
        "transcript": "And then we want to know if um we can build models to then get at the mechanistic steps where basically these um these products then you know, induce all these changes in the body that then translate into effects on the disease. Um I guess another important point was the medications and how they um get affected by the microbiome and then vice versa, how like management of these patients affects the motility and the composition of the microbes. So yeah, I guess Jay's back so.",
        "speaking duration": 44,
        "nods_others": 0,
        "smile_self": 10,
        "smile_other": 100,
        "distracted_others": 0,
        "hand_gesture": "Open Palms",
        "interuption": "No",
        "overlap": "No",
        "screenshare": "Yes",
        "screenshare_content": "A document titled \"Group 1.3 Key points and next steps\" is being shared. The document appears to be a list of bullet points, possibly summarizing key findings or action items. No changes are made to the content during this segment.",
        "start_time": "11:00",
        "end_time": "11:44",
        "annotations": {
            "develop idea": "The speaker is expanding on existing ideas by suggesting the development of models to understand the mechanistic steps involved.",
            "summarize conversation": "The speaker is summarizing and highlighting key points from the discussion.",
            "clarify goal": "The speaker is clarifying goals and areas of investigation."
        }
    },
    {
        "speaker": "Emily Balskus",
        "timestamp": "01:44-01:46",
        "transcript": "Thanks Jay.",
        "speaking duration": 2,
        "nods_others": 0,
        "smile_self": 100,
        "smile_other": 0,
        "distracted_others": 0,
        "hand_gesture": "None",
        "interuption": "No",
        "overlap": "No",
        "screenshare": "Yes",
        "screenshare_content": "A document titled \"Group 1.3 Key points and next steps\" is being shared. The document appears to be a list of bullet points, possibly summarizing key findings or action items. No changes are made to the content during this segment.",
        "start_time": "11:44",
        "end_time": "11:46",
        "annotations": {
            "acknowledge contribution": "Acknowledges Jay's presence, similar to recognizing a group member's input."
        }
    },
    {
        "speaker": "Jae Sung",
        "timestamp": "01:46-01:51",
        "transcript": "All right, I'm going to try to summarize all this to",
        "speaking duration": 5,
        "nods_others": 0,
        "smile_self": 100,
        "smile_other": 0,
        "distracted_others": 0,
        "hand_gesture": "None",
        "interuption": "No",
        "overlap": "No",
        "screenshare": "Yes",
        "screenshare_content": "A document titled \"Group 1.3 Key points and next steps\" is being shared. The document appears to be a list of bullet points, possibly summarizing key findings or action items. No changes are made to the content during this segment.",
        "start_time": "11:46",
        "end_time": "11:51",
        "annotations": {
            "summarize conversation": "The speaker explicitly states their intention to summarize the previous discussion."
        }
    }
]